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As the use of biomacromolecules as therapeutics increases, the challenge of delivering complex biopharmaceuticals,
such as those based on proteins and peptides, becomes more pressing [1,2]. Nanocarriers have been traditionally
decorated with proteins or peptides for targeting purposes but also for promoting cellular uptake [3] and, in the case
of Abraxane, proteins themselves constitute the nanocarrier [4]. Besides the deliberate adsorption or conjugation
of proteins onto nanoparticles, nanomedicines administered by intravenous injection will be exposed to high
concentrations of proteins in the serum, which readily adsorb on the surface of the nanoparticles forming the
so-called protein corona. It is fair to say that unless a nanoparticle has been deliberately engineered to repel proteins,
all of them will adsorb proteins at some point during their journey toward the target tissue. It is now well accepted
that the formation of a protein layer surrounding the nanoparticle can have significant effect on the biodistribution
and the efficacy of the targeting strategy [5–8]. For this reason, the ability to carefully engineer the interface between
the nanoparticle and body fluids could play a significant role in future nanomedicines [9,10].
This article focuses on the idea that designer proteins can be used to form a stable protein corona before injection
and exposure to serum proteins. The use of proteins that prevent the formation of a serum protein-rich corona
and carry targeting or cell penetrating domains could potentially elude opsonization, increase tissue specificity and
improve the pharmacokinetics of nanocarriers [5]. However, the controlled adsorption or chemical conjugation of
proteins onto nanoparticles is not straightforward and far from universal, due to the remarkable diversity of protein
structures and chemistries involved. As a consequence, the conjugation method for each nanoparticle/protein pair
would require extensive optimization and this is reflected by the large number of specific functionalization strategies
developed so far [11,12]. As the excessive diversification of methods and chemistries in nanocarriers’ synthesis could
potentially lead to regulatory complications, it is important to study modular strategies to simplify and reduce the
number of molecular building blocks required. Such approach was recently reported in the context of modular
assembly of proteins on gold nanoparticles [13] and it is detailed below.
Modular assembly of proteins on gold nanoparticles
The ‘plug and play’ paradigm in synthetic biology [14] promotes a simple bottom-up approach for the design of
artificial biological entities. In general terms, the end user of a plug and play synthetic biology technology should
be able, in principle, to combine existing building blocks together to obtain a product, without any need of tedious
optimization steps. The modularity of the approach means that some building blocks could be used in more than
one process without modification. In the context of protein conjugation to nanoparticles, it can be useful to use an
analogy with USB power adaptors to highlight the modular nature of the method described here.
To plug and charge different devices (i.e., the proteins) into country-specific sockets (i.e., the nanoparticles),
it would be unpractical to have specifically designed power cords for every device and socket pair. Instead, USB
power adaptors offer the possibility to charge any device presenting a USB plug. Similarly, it would be ideal to
encode a universal tag (i.e., the USB plug) into a recombinant protein. The tag would allow the end user to ‘plug’
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the protein onto any nanoparticle for which an ‘adaptor’ exists. A molecular equivalent of this adaptor has been
recently described [13] for the use with gold nanoparticles. Gold nanoparticles were chosen as a proof-of-concept
and for their general relevance in nanomedicine [15]. Recent examples that make use of biomolecules conjugated to
gold nanoparticles include delivery of Cas9 ribonucleoprotein and donor DNA for in vivo genome editing [16] and
drug delivery across the blood–brain barrier [17].
The part of the ‘adaptor’ that binds to the gold nanoparticle was the enzyme GST from Schistosoma japonicum.
This is a common affinity tag used in protein biochemistry for its ability to bind glutathione-modified resins.
It was discovered that GST also adsorbs onto citrate-capped gold nanoparticles with remarkable affinity and the
mechanism of binding was described [13]. This involves the formation of covalent bonds between gold and sulfur
atoms at cysteine residues (Au-S bonds), which make the binding of GST to gold permanent.
The analog of the adaptor’s USB socket was provided by SpyCatcher, which has the specific ability to bind
recombinant proteins encoding a SpyTag [18]. SpyCatcher/SpyTag consists of a split protein system engineered
from the fibronectin-binding protein FbaB from Streptococcus pyogenes. The two components of the system assemble
together spontaneously and form an unusual isopeptidic bond between the two polypeptides. Specifically, the bond
forms between the amino group of the side chain of a lysine residue on SpyCatcher and the carboxylic group of the
aspartic acid side chain on SpyTag. SpyCatcher was cloned as a C-terminal fusion protein to GST and expressed in
Escherichia coli. GST-SpyCatcher, the ‘adaptor,’ wasmixedwith 40 nmgold nanoparticles and adsorbed permanently
and stably. A SpyTag recombinant fusion to another molecule of GST was then used to form a second layer of
proteins on the nanoparticles. This was obtained again by simple mixing, proving the idea of straightforward,
modular and hierarchical decoration of nanoparticles with protein building blocks.
It is important to note that protein adsorption on metal nanoparticles can lead to protein denaturation and
potentially compromise protein function [19]. Partial denaturation of GST upon adsorption on both gold and silver
was in fact observed [13]. However, as the point of GST in this context was merely to bind firmly to nanoparticles,
the actual function to preserve was not the transferase activity of GST but the ability of GST-fused SpyCatcher
to bind SpyTag-modified proteins. This example highlights that it could be beneficial to have an intermediate
‘sacrificial’ layer of proteins directly adsorbed on the solid surface, whereas the second protein layer would be away
from the metal, with better preservation of structure and function.
Conclusion
Overall, the described method showed the excellent gold-binding properties of GST. For example, human serum
could not displace GST from gold nanoparticles, suggesting that GST-based anchoring could work in vivo.
SpyCatcher/SpyTag system was used as an intermediate for the assembly of a second layer of proteins on top of
GST. Both GST binding to gold and SpyTag binding to SpyCatcher were very efficient and were performed by
simplemixing in equimolar concentrations andmild conditions. Importantly, both interactions led to the formation
of covalent bonds, Au-S bonds on the first protein layer and isopeptidic bonds on the second, thus providing stable
conjugates.
This method is particularly suitable for the decoration of gold nanoparticles with recombinant proteins. The
13 amino acids SpyTag can be easily encoded at the N-terminal or C-terminal of a protein of interest. The short
length of SpyTag suggests that the method can be very versatile and, for example, could include the possibility to
plug into SpyCatcher activated particles any molecule that can be chemically synthesized in association with the
13 amino acids peptide. Using once more the analogy with electronic devices and adaptors, it will be possible to
manufacture many different varieties of ‘devices’ with a SpyTag ‘USB plug’. For example, recent work on virus-like
particles for vaccines used SpyCatcher/SpyTag to display viral epitopes and the modular approach described here
may prove useful in this field [20].
Although the activation of nanoparticles using GST-SpyCatcher was mainly described for citrate-capped gold
nanoparticles, the method was also applied to silver nanoparticles synthesized in the same way, suggesting that the
same building block can be used at least on two materials. The obvious follow-up of this work would be the design
and synthesis of new ‘adaptors’ for nanoparticles other than gold or silver, for example, by fusion of SpyCatcher to
peptides that bind specific materials [12].
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